Silver Oak Securities’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Silver Oak Securities's RMD Position: Q1 2026 in Review
Silver Oak Securities increased its ResMed (RMD) stake by 6.6% in Q1 2026, buying an estimated $114K and bringing the position to 7,340 shares worth $1.65M. The position accounts for 0.12% of the portfolio, ranked #175.
Silver Oak Securities first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.83M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Silver Oak Securities held 7,340 shares of ResMed worth $1.65M as of Q1 2026.
- Silver Oak Securities bought 457 ResMed shares in Q1 2026, an estimated $114K.
- ResMed made up 0.12% of Silver Oak Securities's portfolio in Q1 2026, its #175 holding.
- Silver Oak Securities first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
- Silver Oak Securities's ResMed position peaked at $1.83M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Silver Oak Securities's 13F filing for Q1 2026, filed 20 Apr 2026.